Inqo Investments Ltd - Half-year Results
Announcement provided by
Inqo Investments Limited · INQO27/11/2020 17:00
Unaudited Group Results for the period ended
CHAIRMAN AND CHIEF EXECUTIVE STATEMENT
COMMENTARY
The Group remains in a strong financial position with minimal debt. Cash reserves for investment stood at R7 072 767 with total assets of R169 973 016 on the balance sheet.
The results for the six months under review showed revenue of R1 746 170 (
Depreciation Listing expenses Directors fees and salaries Professional fees |
1 743 117 528 106 300 540 259 942 |
1 531 521 421 117 388 563 248 887 |
Like businesses around the world, the Group has been heavily impacted by the Covid-19 pandemic. The result of this pandemic has been that all the businesses in the Group have reported reduced earnings and are taking extensive steps to reduce operating costs to the absolute minimum while the businesses operate in a holding mode as the world waits to see how the Covid-19 pandemic plays out.
The directors of the holding company review the valuation placed on all income carrying assets to ensure that they reflect their fair value. This review was done at
INVESTEE COMPANIES
Spekboom Trading (
The company has to date replanted some 500 acres of degraded land with spekboom, an indigenous shrub that naturally sequesters exceptionally high levels carbon, creating 100 job opportunities in the process.
The spekboom thicket restoration at Kuzuko is planned to restart once the Covid-19 pandemic crisis has passed and restoration work can commence. A memorandum of understanding is being negotiated with a leading carbon fund to restore 12,500 acres of spekboom on the Kuzuko property in order to generate carbon credits.
There has recently been a renewed interest in the carbon markets in response to the growing global awareness of the impact of climate change with nature-based solutions, such as spekboom, being a high priority. Inqo anticipates scaling up spekboom restoration activities once the Covid-19 pandemic situation has resolved providing valuable employment opportunities as well as a positive environmental benefit.
A small-scale trial plot has just been planted to test the best method for growing spekboom based on the latest scientific research. The next step is to undertake large-scale trials over 40 hectares to refine the cost model of the investment. This will take place as soon as it is feasible (in the context of Covid-19 lockdowns) to run the trials.
Inqo made an initial investment into
The
The hives are harvested twice a year, generally in May and November.
Inqo earned R42 102 as its share of revenue in the period ended
Inqo made an initial investment in 2017 and a further investment in 2018 in
Prior to the Covid-19 pandemic Four-One was performing well having endured challenging operating conditions for the previous 18 months. The impact of the lockdown and subsequent economic downturn is likely to be severe in
Inqo earned interest on its investment in the
SLMC is a private healthcare provider in the Naivasha region of
This hospital receives around 64,000 patient visits per annum with the capacity to treat three times this number. Currently, SLMC offers a range of in and outpatient services including consultations, laboratory testing, radiology and pharmacy services. Following this investment, SLMC will be expanded to include a surgical unit making it the most advanced hospital at the southern end of
The impact of Covid-19 will be economically challenging for SLMC. The major industry in the area is cut flowers for the European market - a sector that has dropped off in the current climate but with the resumption of international flights sales levels are returning. In addition, there is a strong vegetable growing industry in Naivasha that continues to trade and provide medical appointments for SLMC.
Inqo earned interest of R48 424 on its investment in SLMC in the period ended
Kentegra is a Kenyan based biotechnology firm owned by the US holding company,
Kentegra continues to operate in a scaled down manner but has reported demand during the Covid-19 pandemic. They have recently installed a new factory that is in the process of being commissioned and ready for production. The senior management team have responded quickly and professionally drawing up well considered contingency plans for all eventualities and are re-evaluating the situation on a continual basis. Kentegra has shown a strong commitment to both their smallholder farmer partners and their employees during this time, going above and beyond to minimise the economic impact while ensuring safety for the organisation.
STOCK EXCHANGE LISTING
Aquis Exchange PLC (AIM:AQX) acquired the NEX Exchange in
OUTLOOK
Kuzuko Private Game Reserve - The Lodge saw high occupancy rates before the Covid-19 pandemic. Once international tourism re-commences, we are confident that Kuzuko will make a good recovery although it will take time for confidence to return to the tourism industry in
Spekboom Trading - The Covid-19 pandemic has meant that re-planting activity had to cease. However, discussions have been on-going with a number of environment focussed investment funds to start re-planting of spekboom when lockdown is relaxed
Kentegra Biotechnology - As an Agri business, Kentegra was deemed an essential service by the Kenyan government and has been able to continue operations during the lockdown. During this period, the company has on-boarded a significant number of new out-grower farmers as well as installed and commissioned their new factory and made their first export sale.
SUMMARY OF SOCIAL & ENVIRONMENTAL METRICS SINCE PROJECT COMMENCEMENT
· 39,000 acres of former farmland restored as a game reserve in a region of endemic poverty in the poorest province in
· Increased VAT and income tax paid by Kuzuko year on year, currently 46 fulltime staff employed.
· All staff living at Kuzuko in standard housing with flush toilets, power, water and solar panels.
· Conservation of 3 endangered species.
· Re-wilded, bred and released 6 cheetahs with new genetics into the metapopulation in
· Reforestation of 500 acres of degraded land with spekboom providing work for 100 part time staff and sequestering carbon
· 85,512 beehives in the field with positive impact on bee populations and retention of forests
· 2,100+ voluntary low-income savers in micro-pension and loan schemes
· 74,582 patient visits between January and
· Increased the economic livelihoods of over 17,000 farmers and their families in
STAFF
The directors would like to take this opportunity to thank all the operating staff in the Group for their contribution and commitment to the Group's objectives during this challenging time.
FINANCIAL INFORMATION
The financial information set out in this announcement does not constitute statutory financial statements. This financial information has been extracted from Inqo's unaudited group financial statements for the period ended
DIVIDEND
The company has not declared a dividend the period ended
K.S Tan C.J Bertie
Chairman Chief Financial Officer
Enquiries
|
Tel: +27 (0)83 6254069 |
Chris Bertie, Chief Financial Officer and Chief Operating Officer |
Email: cbertie@acland.co.za |
|
|
|
|
AQSE Corporate Adviser and Broker |
Tel: +44 (0)20 7070 5665 |
Dr Wang Chong |
Email: wang.chong@hobartcapital.com |
Condensed consolidated statement of profit or loss and other comprehensive income
for the six months ended 31 August 2020
|
|
|
|
Six Months ended |
|
Six Months ended |
|
|
|
|
|
R |
|
R |
|
Revenue |
|
|
|
1 746 170 |
|
8 738 816 |
|
Cost of Sales |
|
|
|
(240 331) |
|
(1 198 952) |
|
Gross profit |
|
|
|
1 505 839 |
|
7 539 864 |
|
Other income |
|
|
1 252 416 |
|
136 821 |
|
|
Personnel expenses |
|
|
(2 400 248) |
|
(4 048 171) |
|
|
Depreciation |
|
|
(1 743 117) |
|
(1 531 521) |
|
|
Listing expenses |
|
|
(528 106) |
|
(421 117) |
|
|
Professional fees |
|
|
(259 942) |
|
(248 887) |
|
|
Directors emoluments |
|
|
(300 540) |
|
(388 563) |
|
|
Selling and administrative expenses |
|
|
(2 921 969) |
|
(6 883 256) |
|
|
Operating loss |
|
|
|
(5 395 667) |
|
(5 844 830) |
|
Net financing income |
|
|
|
355 206 |
|
247 879 |
|
Finance income |
|
|
|
424 966 |
|
340 465 |
|
Finance costs |
|
|
|
(69 760) |
|
(92 586) |
|
|
|
|
|
|
|
|
|
Loss before taxation |
|
|
|
(5 040 461) |
|
(5 596 951) |
|
Taxation credit |
|
|
|
280 415 |
|
449 647 |
|
Loss for the period |
|
|
|
(4 760 046) |
|
(5 147 304) |
|
Loss attributable to: |
|
|
|
|
|
|
|
Equity holders |
|
|
|
(3 587 714) |
|
(4 236 248) |
|
Non-controlling interest |
|
|
|
(1 172 332) |
|
(911 056) |
|
|
|
|
|
(4 760 046) |
|
(5 147 304) |
|
Other comprehensive income: |
|
|
|
|
|
|
|
Other comprehensive income |
|
|
|
- |
|
- |
|
Total comprehensive income for the period |
|
|
|
(4 760 046) |
|
(5 147 304) |
|
Total comprehensive income attributable to: |
|
|
|
|
|
|
|
Equity holders |
|
|
|
(3 587 714) |
|
(4 236 248) |
|
Non-controlling interest |
|
|
|
(1 172 332) |
|
(911 056) |
|
|
|
|
|
(4 760 046) |
|
(5 147 304) |
|
Condensed consolidated statement of financial position
as at 31 August 2020
|
|
|
Reviewed |
|
Audited |
|
|
|
|
|
R |
|
R |
|
|
Assets |
|
|
|
|
|
|
|
Non-current assets |
|
|
145 802 368 |
|
146 063 205 |
|
|
Property, plant and equipment |
|
|
133 575 459 |
|
134 430 943 |
|
|
Intangible assets |
|
|
6 847 |
|
9 062 |
|
|
Right of use asset |
|
|
790 490 |
|
893 597 |
|
|
Other investments |
|
|
11 429 572 |
|
10 729 603 |
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
18 475 303 |
|
27 644 153 |
|
|
Biological assets |
|
|
3 058 866 |
|
3 058 866 |
|
|
Inventories |
|
|
4 863 586 |
|
4 763 430 |
|
|
Trade and other receivables |
|
|
3 480 084 |
|
4 150 071 |
|
|
Cash and cash equivalents |
|
|
7 072 767 |
|
15 671 786 |
|
|
|
|
|
|
|
|
|
|
Assets held for sale |
|
|
5 695 345 |
|
5 695 345 |
|
|
Land held for sale |
|
|
5 695 345 |
|
5 695 345 |
|
|
|
|
|
|
|
|
|
|
Total assets |
|
|
169 973 016 |
|
179 402 703 |
|
|
Equity and liabilities |
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
|
Ordinary share capital |
|
|
71 809 195 |
|
71 809 195 |
|
|
Share premium |
|
|
86 294 138 |
|
86 294 138 |
|
|
Revaluation reserve |
|
|
73 152 702 |
|
73 152 702 |
|
|
Accumulated loss |
|
|
(73 899 572) |
|
(70 311 858) |
|
|
Equity attributable to equity holders of: Non-controlling interest |
|
|
157 356 463
(398 697) |
|
160 944 177
773 635 |
|
|
Total equity |
|
|
156 957 766 |
|
161 717 812 |
|
|
|
|
|
|
|
|
|
|
Non-current liabilities |
|
|
6 971 713 |
|
7 328 094 |
|
|
Loans from related parties |
|
|
167 846 |
|
167 845 |
|
|
Other long term loans |
|
|
687 580 |
|
668 210 |
|
|
Deferred taxation |
|
|
5 268 973 |
|
5 549 379 |
|
|
Debentures |
|
|
193 457 |
|
193 457 |
|
|
Lease liability |
|
|
653 857 |
|
749 203 |
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
6 043 537 |
|
10 356 797 |
|
|
Trade and other payables |
|
|
5 114 032 |
|
9 494 844 |
|
|
Provision |
|
|
744 006 |
|
686 559 |
|
|
Lease liability |
|
|
185 499 |
|
175 394 |
|
|
Total liabilities |
|
|
13 015 250 |
|
17 684 891 |
|
|
Total equity and liabilities |
|
|
169 973 016 |
|
179 402 703 |
|
|
Condensed consolidated statement of cash flows
for the six months ended 31 August 2020
|
|
|
||
|
|
Six months ended |
|
Six months ended |
|
|
R |
|
R |
Cash flows from operating activities |
|
|
|
|
Net loss before tax |
|
(5 040 461) |
|
(5 596 951) |
Amortisation |
|
2 215 |
|
3 457 |
Depreciation |
|
1 637 795 |
|
1 493 705 |
Depreciation of right of use asset |
|
103 107 |
|
34 370 |
Finance cost on lease liability |
|
50 055 |
|
19 218 |
Loss on disposal of motor vehicle |
|
22 385 |
|
- |
Net working capital changes |
|
|
|
|
Inventory |
|
(100 156) |
|
44 802 |
Trade payables |
|
(4 323 365) |
|
(1 629 147) |
Trade receivables |
|
669 987 |
|
(299 633) |
Net cash outflow from operating activities |
|
(6 978 438) |
|
(5 930 179) |
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
Acquisition of investments |
|
(699 969) |
|
(1 727 606) |
Acquisition of biological assets |
|
- |
|
(229 459) |
Acquisition of property, plant and equipment and intangible assets |
(990 368) |
|
(3 772 495) |
|
Proceeds from disposal of property, plant and equipment and intangible assets |
185 682 |
|
- |
|
Finance lease payments |
|
(135 296) |
|
(45 099) |
Loans advanced to Associates |
|
- |
|
(980 735) |
Net cash outflow from investing activities |
|
(1 639 951) |
|
(6 755 394) |
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
Proceeds of shares issued |
|
- |
|
4 115 250 |
Proceeds of shares issued during the prior period |
|
- |
|
18 210 000 |
Loans and borrowings raised |
|
19 370 |
|
21 428 |
Net cash inflow from financing activities |
|
19 370 |
|
22 346 678 |
Net movement in cash and cash equivalents |
|
(8 599 019) |
|
9 661 105 |
Cash and cash equivalents at beginning of period |
|
15 671 786 |
|
11 557 690 |
Cash and cash equivalents at end of period |
|
7 072 767 |
|
21 218 795 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the